Previous work has shown that the anti-inflammatory metabolite butyrate can reduce HDAC3 expression and prevent the nuclear translocation of NF-κB p65 in AD mice (Hu et al., 2024). The gene discussed is NFKB1; the disease is Alzheimer disease.